These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8853491)
1. Early detection of prostate cancer with PSA: the Washington University experience. Smith DS Can J Oncol; 1994 Nov; 4 Suppl 1():57-62. PubMed ID: 8853491 [No Abstract] [Full Text] [Related]
2. Prostate cancer early detection practices among men with a family history of disease. Bock CH; Peyser PA; Gruber SB; Bonnell SE; Tedesco KL; Cooney KA Urology; 2003 Sep; 62(3):470-5. PubMed ID: 12946749 [TBL] [Abstract][Full Text] [Related]
3. Similar age-specific PSA, complexed PSA, and percent cPSA levels among African-American and white men of southern Louisiana. Prostate-specific antigen. Martin B; Cheli C; Pollard S; Sullivan J; Goodman J; Kokatnur M; Ward M; Martin L; Mercante D; Rayford W Urology; 2003 Feb; 61(2):375-9. PubMed ID: 12597951 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancer detection in Black and White men with abnormal digital rectal examination and prostate specific antigen less then 4 ng./ml. Fowler JE JR; Bigler SA; Farabaugh PB; Wilson SS J Urol; 2000 Dec; 164(6):1961-3. PubMed ID: 11061891 [TBL] [Abstract][Full Text] [Related]
5. Racial differences in operating characteristics of prostate cancer screening tests. Smith DS; Bullock AD; Catalona WJ J Urol; 1997 Nov; 158(5):1861-5; discussion 1865-6. PubMed ID: 9334618 [TBL] [Abstract][Full Text] [Related]
7. Biopsy-based diagnosis of prostate cancer in 1290 patients referred for prostate examination: results according to the PSA level, digital rectal examination and ultrasonography. Szabó J; Végh A; Gasman D; Hoznek A; Chopin DK; Abbou CC Acta Chir Hung; 1998; 37(1-2):95-100. PubMed ID: 10196617 [TBL] [Abstract][Full Text] [Related]
8. Prostate cancer screening with PSA, DRE and TRUS. Cusan L Can J Oncol; 1994 Nov; 4 Suppl 1():63-4. PubMed ID: 8853492 [No Abstract] [Full Text] [Related]
9. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182 [TBL] [Abstract][Full Text] [Related]
10. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients. Porter CR; Kim J Urology; 2004 Jan; 63(1):90-4. PubMed ID: 14751356 [TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen test use and digital rectal examinations among African-American men, 2002-2006. Ross LE; Meade SA; Powe BD; Howard DL J Natl Black Nurses Assoc; 2009 Jul; 20(1):52-8. PubMed ID: 19691184 [TBL] [Abstract][Full Text] [Related]
12. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density. Bangma CH; Kranse R; Blijenberg BG; Schröder FH Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415 [TBL] [Abstract][Full Text] [Related]
13. Lest we abandon digital rectal examination as a screening test for prostate cancer. Basler JW; Thompson IM J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511 [No Abstract] [Full Text] [Related]
14. Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less. Carvalhal GF; Smith DS; Mager DE; Ramos C; Catalona WJ J Urol; 1999 Mar; 161(3):835-9. PubMed ID: 10022696 [TBL] [Abstract][Full Text] [Related]
15. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer. Abdalla I; Ray P; Vaida F; Vijayakumar S Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer screening parameters in a high-risk African-Caribbean population. Bunker CH; Patrick AL; Miljkovic-Gacic I; Konety BR; Belle A; Richard JR; Dhir R Urology; 2004 Apr; 63(4):737-41. PubMed ID: 15072891 [TBL] [Abstract][Full Text] [Related]
17. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy]. Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136 [TBL] [Abstract][Full Text] [Related]
18. Comparing two modalities of screening for prostate cancer: digital rectal examination + transrectal ultrasonography vs. prostate-specific antigen. Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M Tumori; 1995; 81(4):225-9. PubMed ID: 8540115 [TBL] [Abstract][Full Text] [Related]
19. Elevated prostate-specific antigen, abnormal prostate evaluation on digital rectal examination, and transrectal ultrasound and prostate biopsy. Partin AW; Stutzman RE Urol Clin North Am; 1998 Nov; 25(4):581-9, viii. PubMed ID: 10026767 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]